Concerning phthalates in medical equipment used for intravenous purposes.
Washington bill restricts phthalate chemicals in IV medical equipment to reduce patient chemical exposure during medical procedures.
Washington bill restricts phthalate chemicals in IV medical equipment to reduce patient chemical exposure during medical procedures.
HB 2402 restricts the use of phthalates—chemical additives used to soften plastics—in medical equipment designed for intravenous administration. The bill aims to reduce patient exposure to these compounds during medical procedures that involve IV lines, catheters, and related equipment. Washington would join a growing number of states implementing similar restrictions based on health concerns.
Phthalates are endocrine-disrupting chemicals that some research suggests may pose health risks, particularly to vulnerable populations like critically ill patients and infants who may receive multiple IV treatments. Medical equipment accounts for a significant source of phthalate exposure in healthcare settings. Restricting their use could reduce cumulative chemical exposure during medical care, though the actual clinical impact remains debated among researchers.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.